Kamala Harris

Joe Biden

Dean Phillips

Marianne Williamson

Donald Trump

Vivek Ramaswamy

Nikki Haley

Ron DeSantis

Cornel West

Robert F. Kennedy

2024 United States Presidential Election

H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

MarketWatch

United States

Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company

The Danish pharmaceutical giant Lundbeck buys the American company Longboard, specialized in neurological diseases. Lundbeck pays 2.6 billion dollars, equivalent to 27 billion kroner. The Lundbeck share falls around five percent on the Copenhagen stock exchange, while Longboard surges 45 percent in American trading.

Danska läkemedelsjätten Lundbeck köper det amerikanska bolaget Longboard, specialiserat på neurologiska sjukdomar. Lundbeck betalar 2,6 miljarder dollar, motsvarande 27 miljarder kronor. Lundbeckaktien faller omkring fem procent på Köpenhamnsbörsen medan Longboard rusar 45 procent i den amerikanska förhandeln.

Danska Lundbeck köper USA-bolag

Svenska Dagbladet

Schibsted

Stockholm

Stockholm County

Sweden

Danish Lundbeck buys US company

Ad Fontes Media

All Sides

Media Bias/Fact Check

Murdoch family

VALBY, Denmark & LA JOLLA, Calif.--(BUSINESS WIRE)--Oct 14, 2024-

Business Wire

Howard Buffett

Crystal River

Citrus County

Florida

Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline

Both the Danish pharma company and the California-based biotech are focused on treating brain-related diseases.

STAT

The Boston Globe

Boston

Suffolk County

Massachusetts

Lundbeck to buy neurology-focused Longboard Pharmaceuticals in $2.6 billion deal

Green Stock News for the New Green Economy.

Green Stock News

H Lundbeck  agreed to acquire Longboard Pharmaceuticals in a US$2.6 billion deal that boosts its drug pipeline for serious brain diseases.

Business Times

Lundbeck to buy Longboard Pharma in US$2.6 billion deal

The proposed acquisition represents a significant step forward in Lundbeck’s Focused Innovator strategy, adding a highly innovative and complementary product in late-stage development for Developmental and Epileptic Encephalopathies (DEEs) – an area of high unmet medical need The acquisition will enhance and complement Lundbeck’s capabilities and presence within neuro-rare conditions The lead asset, bexicaserin, holds blockbuster potential and i…

pipelinereview

Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline - Pipelinereview

cooley.com

Longboard Pharmaceuticals Announces $2.6 Billion Sale to Lundbeck // Cooley // Global Law Firm

Lundbeck's US acquisition of DKK 17 billion will be the company's largest ever, media write.

Lundbecks amerikanske opkøb på 17 milliarder kroner bliver selskabets største nogensinde, skriver medie.

Dansk medicinalkæmpe på milliardopkøb i USA: Det største nogensinde

avisendanmark.dk

Danish pharmaceutical giant on billion-dollar acquisition in the US: The biggest ever

(Reuters) -Denmark's H Lundbeck A/S has agreed to buy Longboard Pharmaceuticals (LBPH) in a $2.6 billion deal to boost its pipeline of treatments for neuro-rare conditions, sending shares of the US-based company up 43.9% in premarket trading.The companies said Lundbeck will acquire all of Longboard's shares

EMEA Tribune, Breaking News, World News, Latest News, Top Headlines

Denmark's Lundbeck to buy Longboard Pharma in $2.6 billion deal

Stock Markets

channelchek.com

Dagens.dk

ADKhabar

pharmatimes.com

Arutz Sheva

Maariv Online

Jerusalem Post

israelhayom.co.il

Anadolu Ajansı

Israel-Hamas Conflict

Volleyball

Fox News

US Economy

US Politics

Senate

Republican Party

Soccer

Election Day

Hurricanes

Halloween

Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics